FSCNX
Price
$15.03
Change
+$0.18 (+1.21%)
Updated
Apr 24 closing price
Net Assets
4.21B
RLBAX
Price
$33.37
Change
+$0.43 (+1.31%)
Updated
Apr 24 closing price
Net Assets
226.9B
Ad is loading...

FSCNX vs RLBAX

Header iconFSCNX vs RLBAX Comparison
Open Charts FSCNX vs RLBAXBanner chart's image
Fidelity Advisor Asset Manager 60% C
Price$15.03
Change+$0.18 (+1.21%)
VolumeN/A
Net Assets4.21B
American Funds American Balanced R1
Price$33.37
Change+$0.43 (+1.31%)
VolumeN/A
Net Assets226.9B
FSCNX vs RLBAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSCNX vs. RLBAX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSCNX is a Buy and RLBAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 227B vs. FSCNX (4.21B). RLBAX pays higher dividends than FSCNX: RLBAX (1.27) vs FSCNX (0.98). FSCNX was incepted earlier than RLBAX: FSCNX (18 years) vs RLBAX (23 years). FSCNX (1.69) is less costly to investors than RLBAX (1.33). RLBAX is a more actively managed with annual turnover of: 171.00 vs. FSCNX (21.00). FSCNX has a lower initial minimum investment than RLBAX: FSCNX (0) vs RLBAX (250). RLBAX annual gain was more profitable for investors over the last year : 3.37 vs. FSCNX (1.73). RLBAX (31.54) and FSCNX (30.49) have equivalent 5 years return.
FSCNXRLBAXFSCNX / RLBAX
Total Expense Ratio1.691.33127%
Annual Report Gross Expense Ratio1.691.33127%
Fund Existence18 years23 years-
Gain YTD-3.287-1.759187%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets4.21B227B2%
Annual Yield % from dividends0.981.2777%
Returns for 1 year1.733.3751%
Returns for 3 years6.1612.4350%
Returns for 5 years30.4931.5497%
Returns for 10 years32.6641.0380%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYRA0.100.01
+7.02%
Lyra Therapeutics
OTLY9.290.32
+3.57%
Oatly Group AB
SFWL0.990.03
+2.99%
Shengfeng Development Limited
LOGI77.152.20
+2.94%
Logitech International SA
IART16.700.44
+2.71%
Integra LifeSciences Holdings Corp